rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
26
|
pubmed:dateCreated |
1998-1-20
|
pubmed:abstractText |
Endomorphin 1 and endomorphin 2 are newly-discovered endogenous ligands for the mu-opioid receptor. In the present study, responses to intra-arterial injections of endomorphin 1 and 2 were investigated in the hindquarters vascular bed of the rat. Under constant-flow conditions, endomorphin 1 and 2 induced dose-dependent decreases in hindquarters perfusion pressure when injected in doses of 3-100 nmol into the hindquarters perfusion circuit. Vasodilator responses to endomorphin 1 and 2 and met-enkephalin were attenuated by the opioid receptor antagonist naloxone (2 mg/kg i.v.) at a time when vasodilator responses to isoproterenol were not altered. In terms of relative vasodilator activity, endomorphin 1 and 2 were similar to ATP, 100-fold less potent than isoproterenol, and 10,000-fold less potent than acetylcholine. These data demonstrate that endomorphin 1 and 2 have significant naloxone-sensitive vasodilator activity in the hindquarters vascular bed of the rat.
|
pubmed:grant |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Acetylcholine,
http://linkedlifedata.com/resource/pubmed/chemical/Adenosine Triphosphate,
http://linkedlifedata.com/resource/pubmed/chemical/Enkephalin, Methionine,
http://linkedlifedata.com/resource/pubmed/chemical/Isoproterenol,
http://linkedlifedata.com/resource/pubmed/chemical/Naloxone,
http://linkedlifedata.com/resource/pubmed/chemical/Narcotic Antagonists,
http://linkedlifedata.com/resource/pubmed/chemical/Oligopeptides,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Opioid, mu,
http://linkedlifedata.com/resource/pubmed/chemical/Vasodilator Agents,
http://linkedlifedata.com/resource/pubmed/chemical/endomorphin 1,
http://linkedlifedata.com/resource/pubmed/chemical/endomorphin 2
|
pubmed:status |
MEDLINE
|
pubmed:issn |
0024-3205
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
61
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
PL 409-15
|
pubmed:dateRevised |
2007-11-14
|
pubmed:meshHeading |
pubmed-meshheading:9416782-Acetylcholine,
pubmed-meshheading:9416782-Adenosine Triphosphate,
pubmed-meshheading:9416782-Animals,
pubmed-meshheading:9416782-Enkephalin, Methionine,
pubmed-meshheading:9416782-Female,
pubmed-meshheading:9416782-Humans,
pubmed-meshheading:9416782-Isoproterenol,
pubmed-meshheading:9416782-Male,
pubmed-meshheading:9416782-Naloxone,
pubmed-meshheading:9416782-Narcotic Antagonists,
pubmed-meshheading:9416782-Oligopeptides,
pubmed-meshheading:9416782-Rats,
pubmed-meshheading:9416782-Rats, Sprague-Dawley,
pubmed-meshheading:9416782-Receptors, Opioid, mu,
pubmed-meshheading:9416782-Vasodilation,
pubmed-meshheading:9416782-Vasodilator Agents
|
pubmed:year |
1997
|
pubmed:articleTitle |
The endogenous mu-opioid agonists, endomorphin 1 and 2, have vasodilator activity in the hindquarters vascular bed of the rat.
|
pubmed:affiliation |
Department of Pharmacology, Tulane University School of Medicine, New Orleans, Louisiana 70112, USA.
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, U.S. Gov't, P.H.S.,
Research Support, Non-U.S. Gov't
|